全文获取类型
收费全文 | 242237篇 |
免费 | 22545篇 |
国内免费 | 4991篇 |
专业分类
耳鼻咽喉 | 3459篇 |
儿科学 | 4435篇 |
妇产科学 | 3707篇 |
基础医学 | 21842篇 |
口腔科学 | 7778篇 |
临床医学 | 22937篇 |
内科学 | 22728篇 |
皮肤病学 | 2499篇 |
神经病学 | 19083篇 |
特种医学 | 6556篇 |
外国民族医学 | 11篇 |
外科学 | 21843篇 |
综合类 | 37439篇 |
现状与发展 | 12篇 |
一般理论 | 37篇 |
预防医学 | 31121篇 |
眼科学 | 2559篇 |
药学 | 22552篇 |
477篇 | |
中国医学 | 28947篇 |
肿瘤学 | 9751篇 |
出版年
2024年 | 4027篇 |
2023年 | 6393篇 |
2022年 | 10059篇 |
2021年 | 12797篇 |
2020年 | 12133篇 |
2019年 | 13007篇 |
2018年 | 11234篇 |
2017年 | 9836篇 |
2016年 | 8730篇 |
2015年 | 8167篇 |
2014年 | 15715篇 |
2013年 | 16561篇 |
2012年 | 13980篇 |
2011年 | 15078篇 |
2010年 | 12116篇 |
2009年 | 10650篇 |
2008年 | 10000篇 |
2007年 | 9973篇 |
2006年 | 8601篇 |
2005年 | 7221篇 |
2004年 | 6053篇 |
2003年 | 5338篇 |
2002年 | 4149篇 |
2001年 | 3448篇 |
2000年 | 3025篇 |
1999年 | 2465篇 |
1998年 | 2064篇 |
1997年 | 1865篇 |
1996年 | 1497篇 |
1995年 | 1427篇 |
1994年 | 1246篇 |
1993年 | 1125篇 |
1992年 | 1028篇 |
1991年 | 921篇 |
1990年 | 810篇 |
1989年 | 762篇 |
1988年 | 729篇 |
1987年 | 632篇 |
1986年 | 582篇 |
1985年 | 1900篇 |
1984年 | 2165篇 |
1983年 | 1359篇 |
1982年 | 1786篇 |
1981年 | 1244篇 |
1980年 | 1073篇 |
1979年 | 949篇 |
1978年 | 783篇 |
1977年 | 601篇 |
1976年 | 735篇 |
1975年 | 503篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
71.
72.
《Journal of the American Dental Association (1939)》2021,152(10):842-854.e1
BackgroundResults from several randomized controlled trials have shown a beneficial effect of ozone in reducing postsurgical complications after impacted mandibular third-molar surgery, but the literature is lacking a systematic review and meta-analysis.MethodsThe authors conducted this systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines after exclusion and inclusion criteria were applied and the following outcome parameters were evaluated: pain, swelling, trismus, quality of life, number of analgesics consumed, and adverse events. RevMan Cochrane Collaboration software, Version 5.3, was used to perform meta-analysis and the Grading of Recommendation Assessment, Development and Evaluation approach was used to rate the certainty of evidence.ResultsPatients who underwent adjuvant ozone application reported lower pain scores than patients in the control group at 24 hours after surgery (95% CI, –3.94 to –1.56) and at 7 days (95% CI, –1.67 to –0.78). Pooled analysis of all 4 included trials revealed a standardized mean difference (SMD) in swelling of –0.44 at 24 hours, 0.63 at 72 hours, and –0.87 at 7 days after surgery in the experimental group. Higher mean estimates in mouth opening were experienced by patients who received ozone at 24 hours (SMD, 2.74; 95% CI, –1.93 to 7.41; 4 studies, 133 patients), 72 hours (SMD, 2.77; 95% CI, –0.63 to 6.17; 4 studies, 133 patients), and 7 days after surgery (SMD, 1.42 SMD; 95% CI, –1.34 to 4.18; 4 studies, 133 patients).Practical ImplicationsEvidence suggests that adjuvant ozone application can offer some benefit for reducing pain, improving quality of life, and decreasing mean intake of analgesics after impacted mandibular third-molar surgery, but it is not effective in reducing facial swelling and trismus, which paves the way for future research. 相似文献
73.
《Respiratory investigation》2021,59(5):700-705
Apalutamide, a competitive inhibitor of the androgen receptor, is being increasingly used for the treatment of prostate cancer. There have been few reports of interstitial lung disease in clinical trials of apalutamide. However, two cases of apalutamide-induced interstitial lung disease with respiratory failure in Japanese males, who were successfully treated with high-dose corticosteroids, are presented here. These cases suggest that clinicians should be alert to the potentially life-threatening risk of pulmonary toxicity associated with apalutamide treatment. 相似文献
74.
75.
Derrek Schartz Emily Young 《Journal of vascular and interventional radiology : JVIR》2021,32(3):447-452
PurposeTo investigate the reimbursement trends for interventional radiology (IR) procedures from 2012 to 2020.Materials and MethodsReimbursement data from the Physician Fee Schedule look-up tool from the Centers for Medicare and Medicaid Services was compiled for 20 common IR procedures. The authors then investigated compensation trends after adjusting for inflation and from the unadjusted data between 2012 and 2020.ResultsFrom 2012 to 2020, the mean unadjusted reimbursement for procedures decreased by ?6.9% (95% confidence interval [CI], ?13.5% to ?0.34%). This trend was even more profound after inflation was taken into account, with a mean decline in adjusted reimbursement of ?18.7% (95% CI, ?24.4% to ?12.9%) during the study period, with a mean yearly decline of ?2.8%. The difference between the mean unadjusted and adjusted payment amounts was significant (P = .012). Similarly, linear regression analysis of the adjusted average reimbursement across all procedures revealed an overall decline from 2012 to 2020 (R2 = 0.97), indicating a steady decline in reimbursement over time.ConclusionsIn just under a decade, IR has experienced significant reimbursement cuts by Medicare, as demonstrated by both the unadjusted and inflation-adjusted payment trends. Knowledge of these trends is critically important for practicing interventional radiologists, leaders within the field, and legislators, who may play a role in formulating future reimbursement schedules for IR. These data may be used to help support more amenable reimbursement plans to sustain and facilitate the growth of the specialty. 相似文献
76.
Sarah J. Schrauben Haochang Shou Xiaoming Zhang Amanda Hyre Anderson Joseph V. Bonventre Jing Chen Steven Coca Susan L. Furth Jason H. Greenberg Orlando M. Gutierrez Joachim H. Ix James P. Lash Chirag R. Parikh Casey M. Rebholz Venkata Sabbisetti Mark J. Sarnak Michael G. Shlipak Sushrut S. Waikar Paul L. Kimmel Ramachandran S. Vasan Harold I. Feldman Jeffrey R. Schelling 《Journal of the American Society of Nephrology : JASN》2021,32(1):115
77.
目的 总结貌似多发性硬化的皮层下梗死和白质脑病的常染色体显性遗传性脑动脉病(CADASIL)的临床特点.方法 报告1例经基因检查和周围神经活检确诊为CADASIL的临床资料.结果 患者腓肠神经活检可见有髓神经纤维密度轻度减少,电镜下可见神经束膜小动脉中层平滑肌细胞外大量颗粒性电子致密嗜锇颗粒物质(GOM)沉积.基因检测显示Notch3基因4号外显子Cys117Arg突变.结论 为避免CADASIL的漏诊及误诊,凡遇青年反复脑卒中发作,又无高血压、糖尿病等常见的血管病危险因素,虽无偏头痛病史,亦应注意追问家族史并做基因检测和周围神经活检. 相似文献
78.
Objective
Physicians often need uptodate, reliable and with easy access information for clinical decisions evidence based medicine (EBM) databases can be a suitable approach to meet this need. The aim of this study was to assess the knowledge, use and factors affecting the acceptance of EBM and its databases by Iranian medical residents using UTAUT model.Method
The present research is an applied survey, the population of which consisted of 192 medical residents of Shahid Beheshti University of Medical Sciences (SBUMS) in Iran. A questionnaire was used for collecting data and SPSS software was used for data analysis.Results
The results show that the total average score of assistants (range?=?1–5), 2.99 and 2.73 scores were respectively obtained for the awareness and use of EBM databases. The study of factors affecting the acceptance using UTAUT showed that item "performance expectancy" with an average of 3.02 is the most important factor in the acceptance of EBM databases by medical residents and items "effort expectancy", "facilitating conditions" and "social influence" are in their next ranks with an average score of 2.54, 2.45 and 2.14, respectively.Conclusion
The findings of this study showed that the majority of medical residents do not have sufficient awareness and knowledge about concepts of EBM and still not comprehend the necessity of using EBM databases. Therefore, planning for accepting and teaching Evidence based medicine and databases is essential. 相似文献79.
Javariya Aamir Syed Mustafa Ali Maged N. Kamel Boulos Naveed Anjum Muhammad Ishaq 《Health Policy and Technology》2018,7(1):88-97
Objective
The objective of this review is to identify enabling and inhibiting factors for mHealth adoption in low resource settings, by giving emphasis on the stakeholders representing the caregiving side. Another objective of this study is to support implementation agencies (governmental and non-governmental) in designing scalable mHealth interventions.Methods
A PEO (Population, Exposure, Outcome) approach was used to formulate the review question. A pre-defined search strategy was implemented; Google Scholar, PubMed and gray literature were searched using alternate terms for “mHealth”, “adoption” and “developing countries”. CASP [7] tools were used to assess the quality of selected evidence. After applying inclusion and exclusion criteria on search results and critical appraisal of the selected evidence, twelve studies were selected for the review.Results
Adoption factors operated at the levels of organization, facility-based service provider and frontline health worker. Engagement of end users during design phase, informed clinical decision making, utilization of mHealth evidence, employers’ tolerance of some personal use of devices, automation of tasks and user-friendliness of application are key enabling factors for mHealth adoption in developing countries. On the contrary, absence of national policy on mHealth, poor knowledge base on mHealth, using two systems in parallel, duplication of efforts, poor Internet connectivity and shortage of electricity are important inhibiting factors for mHealth adoption.Conclusions
The review provides an insight about the challenges and opportunities related to mHealth adoption in developing countries. Implementation agencies should give careful consideration to these factors before designing and deploying any mHealth-enabled intervention. It is also important to understand the concept of incremental innovation so that resources spent on pilot interventions are optimized and full potential is achieved. 相似文献80.
Ren-Zong Kuo 《Health Policy and Technology》2018,7(4):365-373